Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Valeant has another asset sale in the works

Linette LopezNov 3, 2016, 00:32 IST

YouTube/CNBC

Valeant Pharmaceuticals may sell its eye surgery equipment business, according to Dow Jones.

Talks are still in their preliminary stages, but the business could sell for as much as $2.5 billion.

On Tuesday the company announced that it is in talks to sell one of its core businesses, Salix, to Takeda for $10 billion.

The beleaguered company is trying to sell assets to bring down its over $30 billion in debt.

More on this to come...

NOW WATCH: Here's what happens when interest rates go negative

Please enable Javascript to watch this video